Cosmos Health Inc. (COSM) stock
COSMNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 4/3080% above fair value
$2.49−0.75 (-23.15%)
Close on Nov 16, 2026Market cap $250.58MP/E –Yield –
Cosmos Health profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Cosmos Health's profit margin for the twelve months ending Jun 30, 2026 was -33.1%. For fiscal 2025 it was -29.3%, against -29.7% the year before. The highest annual figure on record is 79.1% in fiscal 2014.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -29.3% | +0.4 |
| FY2024 | Dec 31, 2024 | -29.7% | +5.0 |
| FY2023 | Dec 31, 2023 | -34.7% | −7.3 |
| FY2022 | Dec 31, 2022 | -27.5% | −13.3 |
| FY2021 | Dec 31, 2021 | -14.2% | −15.6 |
| FY2020 | Dec 31, 2020 | 1.5% | +9.8 |
| FY2019 | Dec 31, 2019 | -8.3% | +16.1 |
| FY2018 | Dec 31, 2018 | -24.4% | −3.7 |
| FY2017 | Dec 31, 2017 | -20.7% | −11.8 |
| FY2016 | Dec 31, 2016 | -8.9% | +1244.0 |
| FY2015 | Dec 31, 2015 | -1252.9% | −1332.0 |
| FY2014 | Dec 31, 2014 | 79.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -32.1% | −12.9 |
| Q1 FY2026 | Mar 31, 2026 | -15.6% | −9.7 |
| Q4 FY2025 | Dec 31, 2025 | -51.5% | −28.0 |
| Q3 FY2025 | Sep 30, 2025 | -31.3% | +36.2 |
| Q2 FY2025 | Jun 30, 2025 | -19.2% | +0.4 |
| Q1 FY2025 | Mar 31, 2025 | -6.0% | +6.8 |
| Q4 FY2024 | Dec 31, 2024 | -23.5% | +63.3 |
| Q3 FY2024 | Sep 30, 2024 | -67.5% | −41.4 |
| Q2 FY2024 | Jun 30, 2024 | -19.6% | −11.7 |
| Q1 FY2024 | Mar 31, 2024 | -12.8% | −9.1 |
| Q4 FY2023 | Dec 31, 2023 | -86.8% | +3.0 |
| Q3 FY2023 | Sep 30, 2023 | -26.1% | −9.7 |
| Q2 FY2023 | Jun 30, 2023 | -7.9% | +1.5 |
| Q1 FY2023 | Mar 31, 2023 | -3.7% | −5.3 |
| Q4 FY2022 | Dec 31, 2022 | -89.8% | −80.7 |
| Q3 FY2022 | Sep 30, 2022 | -16.4% | +2.3 |
| Q2 FY2022 | Jun 30, 2022 | -9.4% | −4.3 |
| Q1 FY2022 | Mar 31, 2022 | 1.6% | −3.7 |
| Q4 FY2021 | Dec 31, 2021 | -9.1% | −19.8 |
| Q1 FY2021 | Mar 31, 2021 | -18.7% | −14.7 |
| Q4 FY2020 | Dec 31, 2020 | -5.1% | −5.9 |
| Q3 FY2020 | Sep 30, 2020 | 5.3% | +22.1 |
| Q2 FY2020 | Jun 30, 2020 | 10.7% | +28.8 |
| Q1 FY2020 | Mar 31, 2020 | -4.1% | −1.8 |
| Q4 FY2019 | Dec 31, 2019 | 0.8% | +129.7 |
| Q3 FY2019 | Sep 30, 2019 | -16.9% | −54.6 |
| Q2 FY2019 | Jun 30, 2019 | -18.1% | −26.9 |
| Q1 FY2019 | Mar 31, 2019 | -2.2% | +23.3 |
| Q4 FY2018 | Dec 31, 2018 | -128.9% | −98.3 |
| Q3 FY2018 | Sep 30, 2018 | 37.7% | +39.8 |
| Q2 FY2018 | Jun 30, 2018 | 8.8% | +22.6 |
| Q1 FY2018 | Mar 31, 2018 | -25.5% | +23.9 |
| Q4 FY2017 | Dec 31, 2017 | -30.6% | −20.7 |
| Q3 FY2017 | Sep 30, 2017 | -2.1% | +4.6 |
| Q2 FY2017 | Jun 30, 2017 | -13.7% | −1.8 |
| Q1 FY2017 | Mar 31, 2017 | -49.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -9.9% | – |
| Q3 FY2016 | Sep 30, 2016 | -6.7% | – |
| Q2 FY2016 | Jun 30, 2016 | -11.9% | – |
See a number that looks wrong?